Methylphenidate MR
Methylphenidate hydrochloride (modified-release)
Modified-release methylphenidate treats ADHD and releases medicine over several hours. Brands differ in duration and how you take them. This guide compares brands, explains switching and covers side effects.
Written and clinically reviewed by Adam OdusholaADHD Advanced Practitioner and Clinical Prescribing Pharmacist
Methylphenidate MR: key facts
- What it is
- A modified-release stimulant tablet or capsule for ADHD. Contains methylphenidate: a drug that keeps dopamine and noradrenaline available longer in the brain areas that regulate focus, motivation, and impulse control.
- How it differs from IR
- Immediate-release methylphenidate lasts 3–5 hours and needs multiple doses a day. Modified-release delivers the same drug over 8–12 hours from a single morning dose.
- The most important rule
- Not all brands can be swapped for each other. Brands in the same group on the NHS list of equivalent brands release methylphenidate in the same way and can be switched at the same dose if your prescriber agrees; brands in different groups cannot. The MHRA advises caution with any switch. Never change brand without speaking to your prescriber.
- When it kicks in
- Usually 30–60 minutes after taking. Duration is 8 hours (capsule brands and the Tuzulby chewable tablet) or up to 12 hours (tablet brands).
- Most common early effects
- Reduced appetite through the day, mild headache (drinking enough water may help), dry mouth. Most settle in 2–4 weeks.
- Controlled drug
- Schedule 2. New prescription required each month. Store securely. Never share.
15 licensed UK brands, by release group
Brands in the same group release methylphenidate in a similar way. Brands in different groups do not. Your prescription names one brand: only change brand with your prescriber.
| Brand | Lasts | Guide |
|---|---|---|
| Prolonged-release tablets: ~12-hourConcerta XL and its NHS-listed equivalents · ~12-hour profile · Kixel XL not listed | ||
| Concerta XLTablet (OROS) · Reference product | Up to 12 h | Read guide: Concerta XL |
| Affenid XLTablet | Up to 12 h | Read guide: Affenid XL |
| Xaggitin XLTablet | Up to 12 h | Read guide: Xaggitin XL |
| Xenidate XLTablet | Up to 12 h | Read guide: Xenidate XL |
| DelmosartTablet | Up to 12 h | Read guide: Delmosart |
| Atenza XLTablet | Up to 12 h | Read guide: Atenza XL |
| Matoride XLTablet · Children and young people only | Up to 12 h | Read guide: Matoride XL |
| Kixel XLTablet · Licensed 2023; not on the NHS list of equivalent brands | Up to 12 h | Read guide: Kixel XL |
| 50:50 capsules: 8-hour50:50 · can be sprinkled on food · on the NHS list of equivalent capsules | ||
| Ritalin XLCapsule | Up to 8 h | Read guide: Ritalin XL |
| Meflynate XLCapsule | Up to 8 h | Read guide: Meflynate XL |
| Focusim XLCapsule | Up to 8 h | Read guide: Focusim XL |
| Metyrol XLCapsule | Up to 8 h | Read guide: Metyrol XL |
| Medikinet XL: standalone50:50 · take with food · not with acid-reducing medicines such as omeprazole | ||
| Medikinet XLCapsule · Must be taken with food | Up to 8 h | Read guide: Medikinet XL |
| 30:70 products: 8-hour30% immediate, 70% delayed · no match on the NHS list of equivalent brands · cannot be switched for each other or any other brand | ||
| Equasym XLCapsule · No match on the NHS list of equivalent brands: specialist review to switch | Up to 8 h | Read guide: Equasym XL |
| TuzulbyChewable tablet · ages 6 to 17 · Licensed 2025; not on the NHS list of equivalent brands | About 8 h | Read guide: Tuzulby |
Kixel XL and Tuzulby are licensed but are not on the NHS list of equivalent brands, so no equivalence is assumed for either. Addepta XL is also licensed in the UK but had not been launched when the list was last updated. Source: NHS Specialist Pharmacy Service, Prescribing and switching between modified-release methylphenidate, updated 28 August 2025.
What is methylphenidate MR?
Modified-release methylphenidate gives you the same drug as immediate-release tablets, but over 8–12 hours from one morning dose. Your prescription names one brand: only change brand with your prescriber.
Methylphenidate MR at a glance
| Fact | Detail |
|---|---|
| Active ingredient | Methylphenidate hydrochloride (modified-release)Source: Methylphenidate SmPCs (eMC) |
| Medicine type | Once-daily stimulant tablet or capsule. Schedule 2 controlled drugSource: BNF: methylphenidate hydrochloride |
| Licensed UK brands | 15 brands on sale: 13 grouped on the NHS list of equivalent brands, plus Kixel XL and Tuzulby, which are not on the list yetSource: NHS list of equivalent brands |
| How long it lasts | Up to 8 hours (capsule brands and the Tuzulby chewable tablet) or up to 12 hours (tablet brands)Source: NHS list of equivalent brands |
| Strengths | 5–60 mg capsules, 18–54 mg tablets or 20–40 mg chewable tablets, depending on brandSource: BNF: methylphenidate hydrochloride |
| Usual starting dose | 18 mg (tablet brands) or 5–20 mg (capsule brands) once each morning, depending on brandSource: BNF: methylphenidate hydrochloride |
| Maximum dose | Depends on brand: 54–80 mg a day. Check your brand's guideSource: BNF: methylphenidate hydrochloride |
| Food | Depends on brand. Medikinet XL must be taken with food and Equasym XL before breakfast; the others can be taken with or withoutSource: Methylphenidate SmPCs (eMC) |
| Switching brands | Not all brands can be swapped for each other. Same group on the NHS list: can be switched at the same dose if your prescriber agrees. Different groups: no. The MHRA advises caution with any switchSource: NHS list of equivalent brands |
When it's prescribed
First-line treatment for ADHD in children aged 6 and over and adults, per NICE NG87. Must be prescribed and dispensed by brand name (MHRA guidance).
Pros of methylphenidate MR
- Once-daily dosing: no midday top-up
- Multiple brands available to match different needs (duration, food requirements, swallowing ability)
- Capsule brands can be opened and sprinkled on cold food: useful if swallowing is difficult
- Well-established: the most extensively studied ADHD medication class
- Every brand except Medikinet XL can be taken with acid-reducing medicines such as omeprazole or lansoprazole
Cons of methylphenidate MR
- Not all brands can be swapped for each other: take the brand on your prescription and only change brand with your prescriber
- Medikinet XL must be taken with food, and not with acid-reducing medicines such as omeprazole or with antacids
- Cardiovascular monitoring required before and throughout treatment
- Controlled drug (Schedule 2): stricter prescription rules
- Alcohol causes dose-dumping and forms ethylphenidate: avoid entirely
How does methylphenidate MR work?
Methylphenidate keeps dopamine and noradrenaline available longer in the brain areas that control focus, motivation and impulse control. Each brand releases it differently: tablet brands build steadily for up to 12 hours, while capsule brands and the Tuzulby chewable tablet give two waves over about 8 hours.
Your brain runs on chemical signals. Two of the most important for ADHD are dopamine and noradrenaline.
Dopamine gives tasks emotional weight: the motivation to start and keep going. Noradrenaline keeps your focus sharp and filters out background noise. With ADHD, both are in shorter supply in the key brain areas.
Methylphenidate blocks the brain's recycling transporters for these chemicals: keeping them available longer in the synapse. This isn't the same as amphetamines: methylphenidate slows the drain rather than turning up the tap.
How the modified-release mechanism works:
Tablet brands (Concerta XL and its bioequivalent prolonged-release tablets) release a small part of the dose quickly and the rest gradually through the day. Concerta XL does this with an osmotic pump: about 22% of the dose releases immediately; the remaining 78% is pushed out slowly over 6–7 hours through a tiny hole. The effect rises gradually through the morning. With the OROS-type tablets (Concerta XL, Affenid XL, Atenza XL, Kixel XL, Matoride XL) you may see an empty tablet shell in your stools; this is normal and expected. Xenidate XL, Xaggitin XL and Delmosart are built differently and do not leave a shell.
Capsule brands (Medikinet XL, Ritalin XL, Meflynate XL, Focusim XL, Metyrol XL and Equasym XL) contain two types of pellets, immediate-release and modified-release, giving two overlapping peaks across 8 hours. The split differs by brand. Medikinet XL, Ritalin XL, Meflynate XL, Focusim XL and Metyrol XL release half of each dose straight away and half later. Equasym XL releases 30% straight away and the other 70% more slowly (smaller first peak, larger second).
Medikinet XL's pellet coating needs stomach acid to release the medicine at the right time. That is why acid-reducing medicines such as omeprazole, and antacids, must not be taken with Medikinet XL.
How methylphenidate MR works: visual guide
Follow methylphenidate from dose to effect. Use ADHDnotepad's animated visual medication journey to see how methylphenidate enters the bloodstream and blocks the dopamine and noradrenaline transporters (DAT and NET), keeping these signals active for longer. Modified-release brands spread that same effect across the day in different ways.
ClinicalDeeper clinical detail
Methylphenidate hydrochloride blocks dopamine transporter (DAT) and noradrenaline transporter (NAT) in presynaptic neurons, reducing reuptake and increasing monoaminergic neurotransmission in prefrontal cortical circuits.
Tablet group (prolonged-release, ~12 hours): Concerta XL uses the OROS osmotic delivery system (~22% immediate-release overcoat; ~78% delivered by an osmotic push compartment via a laser-drilled orifice), producing an ascending plasma profile over 12 hours. The other tablets in this group are bioequivalent prolonged-release products (NHS list of equivalent brands) and should not automatically be described as using OROS. No known interaction with acid-reducing medicines or antacids.
Capsule group (biphasic pellet): two pellet populations, uncoated immediate-release and polymer-coated modified-release. Medikinet XL, Ritalin XL, Meflynate XL, Focusim XL and Metyrol XL release 50% of each dose straight away and the other 50% later. Equasym XL releases 30% straight away and the other 70% more slowly. Peak plasma at ~1–2 h and ~4–5 h. Medikinet XL only: release depends on stomach acid, so proton pump inhibitors (such as omeprazole), H2-receptor blockers (such as famotidine) and antacids are contraindicated. Meflynate XL: antacids can considerably lower absorption.
NHS list of equivalent brands: Tablet group (Affenid XL, Atenza XL, Concerta XL, Delmosart, Matoride XL, Xaggitin XL, Xenidate XL): can be swapped within the group at the same dose. Capsule group (Focusim XL, Meflynate XL, Metyrol XL, Ritalin XL): can be swapped within the group at the same dose. Medikinet XL and Equasym XL: cannot be freely switched with other groups. Kixel XL (prolonged-release tablet) and Tuzulby (30:70 prolonged-release chewable tablet, 6 to 17 years) are licensed but not on the list: treat each as its own brand.
How do I take methylphenidate MR?
Take it once in the morning, before 9am as a rough guide (adults on Medikinet XL may take up to two doses, morning and midday). Tablet brands are swallowed whole and Tuzulby is chewed. Capsule brands can be opened and sprinkled on cold soft food. Medikinet XL must be taken with food, and Equasym XL before breakfast.
When to take it
Once in the morning. As a rough guide, take it before 9am to avoid it still being active at bedtime.
With or without food
Depends on your brand. Medikinet XL must be taken with or after food; this is not optional. Equasym XL is taken in the morning before breakfast. The other brands can be taken with or without food. Check your brand's page for the exact rule.
Tablets: swallow whole
Concerta XL, Affenid XL, Atenza XL, Delmosart, Kixel XL, Matoride XL, Xaggitin XL and Xenidate XL must be swallowed whole. Do not crush, cut, or chew them; this destroys the release mechanism and delivers the full dose at once. Tuzulby is the exception: it is a chewable tablet and must be chewed.
Capsules: swallow or sprinkle
Capsule brands (Medikinet XL, Ritalin XL, Meflynate XL, Focusim XL, Metyrol XL and Equasym XL) can be swallowed whole or opened and the pellets sprinkled onto cold soft food such as yoghurt or apple sauce (for Equasym XL, a tablespoon of apple sauce, then a drink of water). Cold food only. Eat immediately. Never crush or chew the pellets.
Missed dose
If it is still morning, take it as soon as you remember. If it is already mid-afternoon, skip it and take the next dose tomorrow. Do not double up.
Alcohol
Avoid entirely. Alcohol can cause the modified-release mechanism to fail, releasing the full dose rapidly (dose-dumping). It also chemically reacts with methylphenidate to form ethylphenidate. Both carry risk.
Before surgery
Tell your surgeon and anaesthetist you take methylphenidate. You will usually be asked not to take it on the day of general anaesthesia. Check with your prescriber in advance.
ClinicalPrescribing and clinical detail
MHRA (September 2022): prescribe and dispense by brand name. Do not substitute without clinical review.
Medikinet XL: food required (affects absorption); proton pump inhibitors, H2-receptor blockers and antacids contraindicated (pH-dependent release).
Concerta XL and tablet group: no known interaction with acid-reducing medicines or antacids; no food requirement; an empty tablet shell in stools is an expected feature of the OROS-type tablets (Concerta XL, Affenid XL, Atenza XL, Kixel XL, Matoride XL), not of Xenidate XL, Xaggitin XL or Delmosart.
Equasym XL: 30:70 release profile; given in the morning before breakfast; standalone; no equivalent brand; do not switch without specialist review.
What should I expect from methylphenidate MR week by week?
It usually starts working 30–60 minutes after your dose. Your prescriber starts low and increases gradually, so expect the first 4–8 weeks to be about finding your dose.
Baseline checks
Your prescriber will check blood pressure, heart rate, weight, and relevant personal and family medical history before starting. Your prescription will name a specific brand: always make sure your pharmacy gives you exactly that one.
Adjustment
Appetite will dip, especially in the afternoon. Headaches are common in week one: drinking enough water and eating regular meals may help. You might feel slightly more alert or on edge. Sleep may be lighter. Most settle by week 2.
Settling in
Most early side effects should be reducing. You should notice clearer focus, better task initiation, and fewer hours lost to distraction. If medication works well for most of the day but wears off too early, don't assume you need a bigger dose: discuss with your prescriber first.
Optimising
You may still be titrating towards the ideal dose. The goal is the dose that manages your symptoms well enough, for long enough, with the fewest side effects. If on an 8-hour capsule brand and coverage isn't lasting the whole day, a 12-hour tablet brand or a small IR top-up may be considered.
Maintenance
Once your dose is stable, reviews move to every 6 months. Blood pressure, heart rate, and weight are checked at each visit.
Treatment review
After a year, your prescriber may suggest a supervised treatment break: to check whether the medication is still needed and whether the dose is still right.
What are the side effects of methylphenidate MR?
Reduced appetite, mild headache and dry mouth are the most common early effects. Most settle within 2–4 weeks.
All expanded by default: tap a category to collapse it. Most of these ease in the first 1–2 weeks.
Reduced appetite: especially through the afternoon; weight loss with long-term use
Common to very common, depending on the brandWeight is monitored at reviews.
What helps
- Eat a proper breakfast around the time of your morning dose.
- Appetite usually returns in the evening: plan your main meal for then.
- If you can, prepare it earlier in the day, while the medicine is working.
- Balanced ready-to-heat meals (freshly made, not processed microwave meals) save the planning that stops many people eating.
Nausea, stomach pain, dry mouth, indigestion
Common (nausea and dry mouth are very common in adults with some brands)Most common in the first weeks and usually settles within 1–2 weeks.
What helps
- Eating soon after your dose can help with nausea.
- Drinking enough water and eating regular, smaller meals may help.
- For a dry mouth, sip water and use sugar-free gum or mints.
- Tell your prescriberMention it at your review if it bothers you or is severe.
Difficulty falling asleep: especially if taken too late
Very common (more than 1 in 10)What helps
- Take as early as practical: your brand's guide has an interactive duration & effect chart showing how a change of timing affects when it wears off.
- Cut down on caffeine, especially after midday: it often makes stimulant side effects worse.
- Tell your prescriberIf still disrupted after 4 weeks, discuss with your prescriber: timing or brand may need adjusting.
Waking earlier than usual; lighter sleep
Common (up to 1 in 10)What helps
- Wind-down routine from 9pm; avoid caffeine after midday.
Increased heart rate and blood pressure; palpitations
Common (up to 1 in 10)A modest rise is expected and monitored at every review.
What helps
- Cut down on caffeine and avoid cold and flu remedies that contain a decongestant.
- Keep salt and alcohol down, and keep up regular moderate exercise.
- Tell your prescriberTell your prescriber within a few days if your resting pulse stays above 100. The same if your blood pressure stays at 140/90 or higher (135/85 at home).
- Get help todayA reading of 180/120 or higher after 5 minutes' rest, or a resting pulse above 120: contact your prescriber or 111 today.
Raynaud's phenomenon: fingers or toes going pale or cold
Very rare- Tell your prescriberContact your prescriber.
Anxiety, irritability, low mood or emotional flatness
Common (up to 1 in 10)What helps
- Note when it happens: as the dose is kicking in, while it is working, or as it wears off.
- Get help todayWorsening mood after starting or increasing dose should be reported promptly: not left until the next review.
Suicidal thoughts
Uncommon (up to 1 in 100)- Get help todayContact your prescriber or crisis support immediately.
- Call 999If you feel you might act on these thoughts, or you have harmed yourself, call 999 or go to A&E.
Psychosis symptoms (hallucinations, paranoia); mania
Uncommon/Rare- Get help todayStop and seek urgent review.
Headache: usually settles by week 2
Very common (more than 1 in 10)Most common in the first 2 weeks and often eases.
What helps
- Drinking enough water and eating regular meals may help.
Dizziness, tremor, tiredness
Common (tremor is uncommon with some brands)What helps
- Don't drive while dizzy.
- Tell your prescriberMention at next review if persistent.
Tics: appearing or worsening
Uncommon or common, depending on the brand- Tell your prescriberTell your prescriber before starting if you have a history of tics or Tourette's.
- Tell your prescriberContact prescriber if tics appear or worsen.
Sweating, hair thinning, teeth grinding, decreased sex drive
Common (up to 1 in 10)- Tell your prescriberMention at next review if troublesome.
Priapism (painful erection lasting more than 2 hours)
Frequency not known: medical emergency- Call 999Attend A&E immediately.
This is the full list for this guide, including uncommon and rare effects. For step-by-step tips on managing the common ones, and when to speak to your prescriber, see prolonged-release methylphenidate tablets side effects, 50:50 modified-release methylphenidate side effects and Equasym XL side effects.
When should I get help while taking methylphenidate MR?
Call 999 for severe or spreading chest pain, severe breathlessness, signs of a stroke, a seizure or a suspected overdose. Call 999 too for a severe allergic reaction: sudden swelling of the lips, mouth or throat, or difficulty breathing. Contact your prescriber or 111 today for mild chest pain, a resting heart rate above 120, fainting, hallucinations or thoughts of self-harm (call 999 if you might act on them). Most other early effects can wait for your next review.
Emergency: call 999 or go to A&E
- Severe chest pain, or chest pain spreading to your arm, jaw or back
- Severe shortness of breath or struggling to breathe
- Suspected stroke: FAST (face drooping, arm weakness, speech difficulty)
- Seizures or loss of consciousness
- Suspected overdose
- Priapism (a painful erection lasting more than 2 hours): go to A&E straight away
- Thoughts of harming yourself or someone else that you feel you might act on, or you have harmed yourself
- Severe allergic reaction (anaphylaxis): sudden swelling of the lips, mouth, throat or tongue, or difficulty breathing or swallowing. Call 999.
Monitor at home: mention at next review
Expected effects in the first few weeks
- Reduced appetite, stable and gradually improving
- Mild headache in weeks 1–2
- Dry mouth, thirst
- Mild sleep difficulty: try taking dose 30 minutes earlier
- Mild irritability that is already improving
- Empty tablet shell visible in stools (OROS-type tablets): normal and expected
Contact your prescriber within a few days
Not urgent: but worth discussing if ongoing
- Resting HR consistently above 100 bpm, or ongoing palpitations
- BP persistently raised above your usual readings
- Headaches lasting beyond 2 weeks
- Mood changes, anxiety, or irritability not settling at 4 weeks
- Sleep severely disrupted beyond 4 weeks
- Significant or rapid weight loss
- Tics appearing or worsening
- Blurred vision; Raynaud's symptoms
Contact prescriber or 111 today
Do not wait for a routine appointment
- Mild chest pain or chest tightness
- Resting HR above 120 bpm; BP significantly raised; fainting
- Suicidal thoughts or thoughts of self-harm
- Hallucinations, severe paranoia, or other psychotic symptoms
- A widespread rash, without swelling or breathing problems
- New mania symptoms
- Severe abdominal pain
- Signs of very high blood pressure (severe headache, vision changes, confusion)
What you can safely try while waiting for a review
- Headache: drink more water; avoid caffeine after midday
- Appetite: have a proper breakfast around your morning dose; keep nutritious snacks for the evening
- Sleep: take your dose 30 minutes earlier; avoid screens after 10pm
- Anxiety: track whether worse on dose days vs off days: helps your prescriber
- Dry mouth: sugar-free gum; frequent small sips of water
Frequently asked questions about methylphenidate MR
My pharmacy gave me a different brand. Is that okay?
Not without speaking to your prescriber first. Not all methylphenidate MR brands can be swapped for each other. The NHS list of equivalent brands groups the brands that release methylphenidate in the same way: your prescriber can switch you within your group at the same dose if a brand is out of stock. A brand from a different group has a different release pattern, food rules or mechanism, and the MHRA advises caution with any switch. Swapping without review can mean the medication either peaks too early or doesn't cover the afternoon.
If your pharmacy doesn't have your brand in stock, ask them to order it. If there's an extended supply problem, contact your prescriber for guidance.
Can I drink alcohol?
No: avoid alcohol entirely while taking methylphenidate MR. Alcohol can cause the modified-release mechanism to fail and dump the full dose rapidly into your system (dose-dumping). It also chemically reacts with methylphenidate to form ethylphenidate, which has its own effects. Both carry risk. Even moderate amounts are not safe with this medication.
Will it show up on a drug test?
Yes. Methylphenidate will produce a positive result on urine drug screening: including workplace tests and sports anti-doping tests. Carry documentation of your prescription if you are subject to testing.
Do I have to take it every day?
Not necessarily. Methylphenidate MR clears your body within 12 hours: unlike some medications that need to build up over time. Some people choose not to take it at weekends or on lower-demand days. This is a conversation to have with your prescriber: not something to start unilaterally.
Will I become addicted?
When used as prescribed at therapeutic doses, methylphenidate MR has a low addiction risk. The modified-release formulation produces slow, controlled plasma levels: avoiding the rapid peaks associated with misuse. Methylphenidate is a Schedule 2 Controlled Drug because of its misuse potential when diverted, not because therapeutic use carries significant addiction risk. If you have a history of substance misuse, tell your prescriber; it is relevant but does not automatically exclude this medication.
What's the difference between all the brands?
All brands contain the same active ingredient. The differences are in how they release it: which affects the timing of the effect across the day, whether food is required, and whether the release is sensitive to stomach acid. Some people do better on one brand than another. If your current brand isn't working well, the right conversation is about which brand to try next: not just whether to increase the dose.
I've been switched to a different brand; it doesn't feel the same. Am I imagining it?
No. Even brands that are technically bioequivalent: meaning they have the same average pharmacokinetic profile: can feel different from person to person. Individual variation in how you absorb and respond to a specific formulation is real and recognised. Some people find one brand more effective, longer-lasting, or better tolerated than another, even within the same bioequivalence group.
If you've been switched brands and you've noticed a change in how well it works, how long it lasts, or what side effects you get: that's worth raising with your prescriber. It doesn't mean something is wrong with you. It means you may simply do better on a specific brand.
I take omeprazole or lansoprazole for reflux. Is that a problem?
It depends on your brand. If you take Medikinet XL: yes, this is a significant interaction. Omeprazole, lansoprazole, famotidine and antacids all reduce stomach acid. Medikinet XL's modified-release coating needs stomach acid to work correctly: without it, the coating breaks down early and the full dose is released at once. These medicines must not be taken with Medikinet XL.
If you take any other brand, this is not a problem: none of them is known to interact with omeprazole or lansoprazole. If you take Meflynate XL, check with your pharmacist or prescriber before taking antacids such as Gaviscon or Rennie: they can reduce how much medicine your body absorbs. Tell your prescriber if you've recently started or stopped an acid-reducing medicine.
What about pregnancy?
Do not stop suddenly without speaking to your prescriber. Current evidence (BUMPS/UKTIS) doesn't clearly show an increased risk of birth defects at therapeutic doses, but a small risk of heart defects in very early pregnancy cannot be ruled out. There may be a small effect on fetal growth. Untreated ADHD in pregnancy carries its own risks: the decision about whether to continue, switch, or pause needs to be made with your prescriber.
Can I breastfeed while taking methylphenidate?
Methylphenidate is considered the stimulant of choice for women who want to breastfeed and continue ADHD treatment (Breastfeeding Network). Methylphenidate levels in breast milk are very low. You do not need to stop breastfeeding. Use the lowest effective dose, time doses after a feed where possible, and monitor your baby for unusual irritability, sleep changes, or feeding difficulties.
What should I ask my prescriber about methylphenidate MR?
Questions worth raising at your next review. You don't need to cover all of them: pick the ones that feel most relevant.
- Which brand have you prescribed for me: and why that one?
- What dose are we starting at, and what is the maximum?
- How long before we know if this dose is right?
- Do I need to take it with food? Can I open the capsule if I struggle to swallow?
- What if my pharmacy can't get my specific brand?
- Which side effects should I call you about rather than wait?
- What blood pressure and heart rate numbers would concern you?
- I take [list medications: especially acid-suppression drugs, antidepressants, or BP medications]: are any of these a concern?
- I have a history of tics: does that change anything?
- If this brand doesn't work well enough, what would we try next?
- How long will I stay on this, and will there be a planned treatment break?
- I travel abroad: what do I need to know about carrying a Schedule 2 prescription?
Methylphenidate MR: notes for GPs and clinicians
Clinical notes by Adam Odushola, ADHD Advanced Practitioner and Clinical Prescribing Pharmacist.
ClinicalBrand non-interchangeability: MHRA September 2022
Methylphenidate MR products must be prescribed and dispensed by brand name. Products have clinically different pharmacokinetic profiles: different IR:MR ratios, mechanisms, food requirements.
SPS bioequivalence groups (August 2025): - 12h tablet group (interchangeable within group if needed): Affenid XL, Atenza XL, Concerta XL, Delmosart, Matoride XL, Xaggitin XL, Xenidate XL - 8h capsule group (interchangeable within group with care): Focusim XL, Meflynate XL, Metyrol XL, Ritalin XL - Medikinet XL: switches possible but need care: not fully bioequivalent with capsule group; food requirement applies - Equasym XL: no equivalent: do not switch without specialist review - Kixel XL (prolonged-release tablet, licensed 2023): not in the SPS list; its SmPC names no reference product, so no equivalence is claimed - Tuzulby (30:70 prolonged-release chewable tablet, 6 to 17 years, licensed 2025): not in the SPS list; not interchangeable with Equasym XL
Cross-group switches always require clinical review and dose reassessment.
Note on individual variation: Bioequivalence describes population-average pharmacokinetic equivalence. Individual patients may report meaningful differences in efficacy, side effect profile, or duration between brands within the same bioequivalence group. Patient reports of a difference after a brand switch should not be dismissed. Where supply allows, prescribing the patient's preferred brand within their bioequivalence group is appropriate.
ClinicalAdult licensing
Most methylphenidate MR brands are licensed for children aged 6 and over and adults (see each brand's SmPC). Equasym XL is licensed for children only, Tuzulby for ages 6 to 17, and Matoride XL for children with continuation into adulthood only. NICE NG87 recommends methylphenidate as first-line for adults alongside lisdexamfetamine. Shared care does not transfer clinical responsibility from the initiating specialist.
ClinicalCardiovascular monitoring
BP and HR at baseline, each dose change, and minimum every 6 months. Weight at each review. Screen for personal and family cardiac history before initiation.
Thresholds for action: resting HR >100 bpm: review dose before increasing; systolic BP >140 or diastolic >90 mmHg: review before dose increase. Consider ECG if personal or family history of arrhythmia or structural heart disease.
ClinicalKey interactions
MAOIs: contraindicated; 14-day washout required. Alcohol: ethylphenidate formation (CES1A1 pathway) + dose-dumping risk with MR formulations. PPIs/H2-blockers/antacids: contraindicated with Medikinet XL specifically (pH-dependent release); no other MR SmPC lists PPIs or H2-blockers as an interaction. Meflynate XL: antacids expected to considerably lower absorption (SmPC 4.5). Antihypertensives: methylphenidate may reduce antihypertensive efficacy; monitor BP. Coumarin anticoagulants: methylphenidate may inhibit CYP2C9; monitor INR. TCAs/SSRIs/SNRIs: serotonin syndrome risk; use with caution. Alpha-2 agonists (clonidine, guanfacine): combination used in ADHD; requires monitoring.
ClinicalPregnancy and breastfeeding
Pregnancy (BUMPS/UKTIS January 2023): Not clearly teratogenic at therapeutic doses; small increased risk of cardiac defects in early pregnancy cannot be excluded; potential for fetal growth restriction; neonatal adaptation syndrome possible near delivery. Do not advise abrupt discontinuation. Individual risk-benefit discussion with specialist, obstetrician, and patient.
Breastfeeding (BfN April 2025): Methylphenidate is the stimulant of choice during breastfeeding. RID very low. Women do not need to stop breastfeeding. Advise: lowest effective dose; time doses after a feed; monitor baby for irritability, sleep changes, feeding difficulties.
Patient page: How shared care works, and what to do if your GP declines or stops it
This guide is written for educational purposes and does not constitute medical advice. Always follow the guidance of your prescriber or pharmacist. If you have concerns about your medication, contact your clinical team.
Sources
- NICE guideline NG87: Attention deficit hyperactivity disorder: diagnosis and management. NICE
- Methylphenidate hydrochloride (BNF drug monograph). BNF, NICE
- Medicines containing methylphenidate hydrochloride (all UK SmPCs). electronic medicines compendium (eMC)
- Prescribing and switching between modified-release methylphenidate. Specialist Pharmacy Service (SPS)
- Use of methylphenidate in pregnancy (patient leaflet). BUMPS / UK Teratology Information Service
- ADHD and breastfeeding (factsheet). The Breastfeeding Network
About this guide
- Written and clinically reviewed by
- Adam OdusholaADHD Advanced Practitioner and Clinical Prescribing Pharmacist
- First published
- Last updated
- Last reviewed
- Next review
- What changed
- October 2026: Kixel XL and Tuzulby added to the brand table (not on the NHS list of equivalent brands), and the wording on switching now says which brands can be swapped. Also clearer advice on when to call 999 (severe or spreading chest pain, severe breathlessness, or thoughts of self-harm you might act on) and when to get help the same day. Side effect frequencies now use the categories in the product information (SmPC). The headache advice now says drinking enough water may help, instead of naming dehydration as the cause. Signs of very high blood pressure (severe headache, vision changes, confusion) added to the same-day list. Kixel XL and Tuzulby are described as not on the NHS list of equivalent brands, no longer as not yet on it.
“Last updated” is when the content last changed. “Last reviewed” is when it was last checked against current sources.
How this content is written, sourced and checked: editorial policy
Spotted an error? Report it by email. This is for website feedback only. It can’t give advice about your own treatment.
Changing brand, or to immediate-release? Check the dose conversion
See how your dose lines up with immediate-release methylphenidate or another brand, and how the day’s doses would be spaced. It is a guide for the conversation with your prescriber, not a prescription.
No listed match for 20 mg a day
Concerta XL’s conversion table lists immediate-release totals of 15, 30, 45, 60 mg a day. Your total is 20 mg a day, so your prescriber would choose between the nearest rows (15 mg and 30 mg a day) and review you.
- How to take it: swallow whole. Do not crush, cut or chew.
- This is a guide for the conversation with your prescriber, not a prescription. Your prescriber sets the dose, the start date and the review.
Doses from each product’s manufacturer conversion table and the NHS list of equivalent brands. Read more about switching methylphenidate brands safely.